Skip to main content

Weight Management At The Face Place

  • Indicated for weight management in adults with obesity (BMI ≥ 30 kg/m²), or overweight (BMI ≥ 27 kg/m²) with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity.
  • Contains the active ingredient liraglutide.
  • Prescription medicine; use only as directed by a health professional. Individual results may vary. See Consumer Medicine Information for details.
  • Indicated for chronic weight management in adults with obesity (BMI ≥ 30 kg/m²), or overweight (BMI ≥ 27 kg/m²) with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity.
  • Contains the active ingredient semaglutide.
  • Prescription medicine; use only as directed by a health professional. Individual results may vary. See Consumer Medicine Information for details.
  • Wegovy® is an unfunded medicine in New Zealand; patients are responsible for medicine and associated clinic or pharmacy fees.